Invisible_JJ '_' second_MD skin_NN1 '_' reverses_VVZ signs_NN2 of_IO ageing_NN1 –_– for_IF 24_MC hours_NNT2 

An_AT1 invisible_JJ "_" second_MD skin_NN1 "_" that_DD1 scientists_NN2 have_VH0 developed_VVN that_DD1 can_VM banish_VVI bags_NN2 and_CC wrinkles_NN2 and_CC could_VM be_VBI used_VVN to_TO treat_VVI medical_JJ conditions_NN2 as_II31 well_II32 as_II33 the_AT visible_JJ signs_NN2 of_IO ageing_NN1 ._. Picture_NN1 :_: PA_NP1 
An_AT1 invisible_JJ "_" second_MD skin_NN1 "_" has_VHZ been_VBN developed_VVN that_DD1 irons_VVZ out_RP wrinkles_NN2 ,_, eliminates_VVZ eye_NN1 bags_NN2 ,_, and_CC can_VM banish_VVI visible_JJ signs_NN2 of_IO ageing_NN1 in_II an_AT1 instant_NNT1 ._. 
The_AT new_JJ material_NN1 ,_, applied_VVN in_II a_AT1 two-step_JJ process_NN1 ,_, both_RR protects_VVZ and_CC tightens_VVZ the_AT skin_NN1 ,_, while_CS allowing_VVG it_PPH1 to_TO hold_VVI moisture_NN1 and_CC breathe_VVI ._. 
It_PPH1 has_VHZ the_AT potential_NN1 to_TO make_VVI anyone_PN1 on_II the_AT wrong_JJ side_NN1 of_IO 40_MC look_VVI years_NNT2 younger_JJR –_– but_CCB currently_RR ,_, the_AT effect_NN1 only_RR lasts_VVZ 24_MC hours_NNT2 ._. 
Scientists_NN2 expect_VV0 the_AT silicon-based_JJ "_" biomimetic_JJ film_NN1 "_" will_VM initially_RR be_VBI used_VVN for_IF medical_JJ purposes_NN2 ,_, such_II21 as_II22 treating_VVG dermatitis_NN1 and_CC other_JJ skin_NN1 conditions_NN2 ._. 
As_II31 well_II32 as_II33 appealing_VVG to_II the_AT vain_NN1 ,_, the_AT "_" skin_NN1 "_" could_VM in_II future_NN1 be_VBI used_VVN to_TO dress_VVI wounds_NN2 ,_, screen_VVI out_RP harmful_JJ sun_NN1 rays_NN2 ,_, or_CC deliver_VVI pharmaceutical_JJ drugs_NN2 ._. 
Professor_NNB Robert_NP1 Langer_NP1 ,_, who_PNQS led_VVD the_AT team_NN1 from_II the_AT Massachusetts_NP1 Institute_NP1 of_IO Technology_NP1 (_( MIT_NP1 )_) in_II the_AT US_NP1 ,_, said_VVD :_: "_" Developing_VVG a_AT1 second_MD skin_NN1 that_DD1 is_VBZ invisible_JJ ,_, comfortable_JJ and_CC effective_JJ in_II holding_VVG in_RP water_NN1 and_CC potentially_RR other_JJ materials_NN2 presents_VVZ many_DA2 different_JJ challenges_NN2 ._. 
"_" It_PPH1 has_VHZ to_TO have_VHI the_AT right_JJ optical_JJ properties_NN2 ,_, otherwise_RR it_PPH1 wo_VM n't_XX look_VVI good_JJ ,_, and_CC it_PPH1 has_VHZ to_TO have_VHI the_AT right_JJ mechanical_JJ properties_NN2 ,_, otherwise_RR it_PPH1 wo_VM n't_XX have_VHI the_AT right_JJ strength_NN1 and_CC it_PPH1 wo_VM n't_XX perform_VVI correctly_RR ._. 
"_" We_PPIS2 are_VBR extremely_RR excited_VVN about_II the_AT opportunities_NN2 that_DD1 are_VBR presented_VVN as_II a_AT1 result_NN1 of_IO this_DD1 work_NN1 and_CC look_VV0 forward_RL to_II further_RRR developing_VVG these_DD2 materials_NN2 to_TO better_JJR treat_VVI patients_NN2 who_PNQS suffer_VV0 from_II a_AT1 variety_NN1 of_IO skin_NN1 conditions_NN2 ._. "_" 
The_AT material_NN1 ,_, called_VVN XPL_NP1 ,_, was_VBDZ developed_VVN over_II five_MC years_NNT2 of_IO research_NN1 during_II which_DDQ more_DAR than_CSN 100_MC different_JJ polymers_NN2 –_– large_JJ molecules_NN2 made_VVN up_RP of_IO linked_JJ smaller_JJR units_NN2 –_– were_VBDR tested_VVN ._. 
All_DB contained_VVD a_AT1 chemical_JJ structure_NN1 known_VVN as_II siloxane_NN1 ,_, a_AT1 chain_NN1 of_IO alternating_JJ atoms_NN2 of_IO silicon_NN1 and_CC oxygen_NN1 ._. 
The_AT winning_JJ formula_NN1 produced_VVD an_AT1 elastic_JJ transparent_JJ material_NN1 composed_VVN of_IO cross-linked_JJ molecules_NN2 which_DDQ can_VM be_VBI stretched_VVN invisibly_RR over_II the_AT skin_NN1 ._. 
XPL_NP1 is_VBZ applied_VVN as_II a_AT1 cream_NN1 or_CC ointment_NN1 in_II two_MC layers_NN2 ._. The_AT first_MD contains_VVZ the_AT key_JJ components_NN2 and_CC the_AT second_MD a_AT1 platinum_NN1 catalyst_NN1 that_DD1 causes_VVZ the_AT material_NN1 to_TO stiffen_VVI into_II a_AT1 resilient_JJ coating_NN1 which_DDQ remains_VVZ in_II place_NN1 for_IF 24_MC hours_NNT2 ._. 
In_II elasticity_NN1 tests_NN2 ,_, the_AT material_NN1 easily_RR bounced_VVD back_RP to_II its_APPGE original_JJ state_NN1 after_II being_VBG stretched_VVN by_II more_DAR than_CSN 250_MC %_NNU –_– outperforming_VVG natural_JJ skin_NN1 which_DDQ can_VM only_RR be_VBI stretched_VVN by_RP about_II 180_MC %_NNU ._. 
Other_JJ studies_NN2 conducted_VVN with_IW the_AT help_NN1 of_IO volunteers_NN2 showed_VVD how_RRQ XPL_NP1 tightened_VVD skin_NN1 under_II the_AT eyes_NN2 to_TO remove_VVI sagging_JJ bags_NN2 ,_, and_CC improved_VVD the_AT stretchability_NN1 of_IO skin_NN1 on_II the_AT forearms_NN2 ._. 
Skin_NN1 covered_VVN by_II the_AT film_NN1 was_VBDZ also_RR able_JK to_TO retain_VVI much_DA1 more_DAR water_NN1 than_CSN when_CS treated_VVN with_IW a_AT1 top-of-the-range_JJ commercial_JJ moisturiser_NN1 ._. 
Dermatologist_NN1 Professor_NNB Barbara_NP1 Gilchrest_NP1 ,_, from_II Massachusetts_NP1 General_JJ Hospital_NP1 ,_, another_DD1 member_NN1 of_IO the_AT team_NN1 whose_DDQGE work_NN1 is_VBZ described_VVN in_II the_AT journal_NN1 Nature_NP1 Materials_NP2 ,_, said_VVD :_: "_" Creating_VVG a_AT1 material_NN1 that_DD1 behaves_VVZ like_II skin_NN1 is_VBZ very_RG difficult_JJ ._. 
"_" Many_DA2 people_NN have_VH0 tried_VVN to_TO do_VDI this_DD1 ,_, and_CC the_AT materials_NN2 that_DD1 have_VH0 been_VBN available_JJ up_II21 until_II22 this_DD1 have_VH0 not_XX had_VHN the_AT properties_NN2 of_IO being_VBG flexible_JJ ,_, comfortable_JJ ,_, non-irritating_JJ ,_, and_CC able_JK to_TO conform_VVI to_II the_AT movement_NN1 of_IO the_AT skin_NN1 and_CC return_VVI to_II its_APPGE original_JJ shape_NN1 ._. "_" 
None_PN of_IO the_AT volunteers_NN2 reported_VVD any_DD irritation_NN1 to_II the_AT skin_NN1 caused_VVN by_II wearing_VVG XPL_NP1 ._. 
The_AT scientists_NN2 wrote_VVD :_: "_" We_PPIS2 report_VV0 here_RL that_CST a_AT1 new_JJ ,_, two-step_JJ ,_, flowable_JJ polysiloxane-based_JJ formulation_NN1 ,_, applied_VVN topically_RR and_CC cross-linked_JJ in_RR21 situ_RR22 to_TO form_VVI an_AT1 '_' invisible_JJ '_' thin_JJ film_NN1 on_II human_JJ skin_NN1 ,_, can_VM provide_VVI a_AT1 durable_JJ ,_, skin-conforming_JJ elastic_JJ '_' second_MC skin_NN1 '_' ._. 
"_" This_DD1 '_' second_MC skin_NN1 '_' is_VBZ wearable_JJ ,_, moisturising_JJ ,_, safe_JJ ,_, well_RR tolerated_JJ ,_, and_CC provides_VVZ enhanced_JJ mechanical_JJ integrity_NN1 to_II the_AT underlying_JJ skin_NN1 ._. 
"_" The_AT proof-of-concept_JJ human_JJ studies_NN2 showed_VVD that_CST XPL_NP1 contraction_NN1 reliably_RR reshapes_VVZ the_AT skin_NN1 surface_NN1 ,_, as_II31 well_II32 as_II33 mechanically_RR flattening_VVG herniated_JJ fat_NN1 pads_NN2 that_DD1 cause_VV0 under-eye_JJ bagging_NN1 ._. "_" 
The_AT team_NN1 included_VVD researchers_NN2 from_II US_NP1 hair_NN1 product_NN1 and_CC skin_NN1 care_NN1 company_NN1 Living_JJ Proof_NP1 Inc_NP1 ._. 
A_AT1 new_JJ company_NN1 ,_, Olivo_NP1 Labs_NP2 ,_, has_VHZ been_VBN spun_VVN out_II21 of_II22 Living_JJ Proof_NP1 Inc_NP1 to_TO focus_VVI on_II developing_VVG the_AT XPL_NP1 technology_NN1 ._. 
